Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
This study is ongoing, but not recruiting participants.
Study NCT00002465 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: July 23, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Endometrial Cancer
Malignant Mesothelioma
Additional conditions recognized in this trial
Breast Neoplasms
Endometrial Neoplasms
Mesothelioma
More general conditions related to this trial
Adenoma
Breast Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Neoplasms, Mesothelial
Skin Diseases
Urogenital Neoplasms
Uterine Diseases
Uterine Neoplasms
Interventions listed in this trial
megestrol acetate
Additional drug interventions recognized in this trial
Megestrol
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Appetite Stimulants
Central Nervous System Agents
Central Nervous System Stimulants
Contraceptive Agents
Contraceptive Agents, Female
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
St. Vincent Medical Center - Los Angeles
Back to top of Main Content
